Cornerstone Planning Group
BNTC icon

Cornerstone Planning Group’s Benitec Biopharma BNTC Stock Holding History

Cornerstone Planning Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-46
Closed -$526 – 363
2026
Q2 		$526 Buy
+46
New +$546 ﹤0.01% 1681

Other funds holding BNTC

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Cornerstone Planning Group's BNTC Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Benitec Biopharma (BNTC) in Q3 2026, closing a stake of 46 shares — an estimated $526 sold.

Cornerstone Planning Group first reported a position in BNTC in Q2 2026 and held it in 1 quarter. The position peaked at $526 in Q2 2026. 4 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Benitec Biopharma position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 46 Benitec Biopharma shares in Q3 2026, an estimated $526.
  • Cornerstone Planning Group first reported a position in Benitec Biopharma in Q2 2026 and held it in 1 quarter.
  • Cornerstone Planning Group's Benitec Biopharma position peaked at $526 in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.